Takeda India recognized as top employer for third consecutive year
Takeda Biopharmaceuticals India has been recognized as a Top Employer by the Top Employers Institute for the third consecutive year . Takeda was also certified as the global Top Employer for 2023 , making it the sixth consecutive year in a row for Takeda globally . Additionally , Takeda has been recognized as a top employer across 22 countries strengthening its commitment to creating a diverse , equitable , and inclusive working environment and an exceptional employee experience . Takeda is among 15 companies worldwide to receive global certification for the year 2023 . Serina Fischer , General Manager , Takeda Biopharmaceuticals India Private Limited said , “ We strive to create a working environment where our teams feel valued , and respected and are empowered to make a meaningful difference in the lives of patients .
Panacea Biotec donates 125,000 doses of Easyfive-TT to Cuba
Panacea Biotec on humanitarian grounds has donated 125,000 single dose vials ( SDVs ) of its WHO Prequalified Pentavalent vaccine , Easyfive-TT , to the Ministry of Health of Republic of Cuba for use in Cuba National Health System specifically in the expanded immunization program due to current ongoing shortage of the wP based Pentavalent Vaccine in Cuba . Speaking on the occasion , Dr Rajesh Jain , Chairman & Managing Director , Panacea Biotec said , “ Panacea Biotec believes in giving a chance for Better health . The government has time and again emphasized “ Vasudhaiva Kutumbakam ” meaning the “ World is one Family ”. Our donation is a small step in our continuous strive for Indian science and capabilities for the benefit of all .”
Cipla & Ethris partner for the development of mRNAbased therapies
Cipla Limited has announced that its wholly owned UK subsidiary , Cipla ( EU ) Limited has signed definitive agreements for equity investment of EUR 15 million in Ethris GmbH , a global leader in delivering mRNAs
BioTech
BIOVOICENEWS . COM 9